Secondary hyperparathyroidism.
D001847:Bone Diseases / Q000209:etiology; D001842:Bone and Bones / Q000166:cytology / Q000378:metabolism; D002118:Calcium / Q000502:physiology; D002128:Calcium Metabolism Disorders / Q000150:complications*; D002277:Carcinoma / Q000150:complications; D000242:Cyclic AMP / Q000502:physiology; D003600:Cytosol / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000009:adverse effects; D006961:Hyperparathyroidism / Q000150:complications; D006962:Hyperparathyroidism, Secondary / Q000145:classification / Q000209:etiology*; D007674:Kidney Diseases / Q000150:complications; D010281:Parathyroid Hormone / Q000378:metabolism / Q000502:physiology*; D010710:Phosphates / Q000378:metabolism; D011547:Pseudohypoparathyroidism / Q000150:complications; D013964:Thyroid Neoplasms / Q000150:complications; D014808:Vitamin D Deficiency / Q000150:complications / Q000503:physiopathology
D010281:Parathyroid Hormone; D010710:Phosphates; D000242:Cyclic AMP; D002118:Calcium; D006854:Hydrocortisone